Introduction: The aim of the study was to introduce a new endoscopic technology, clip-and-snare assisted endoscopic submucosal resection (CS-ESMR), for treatment of rectal neuroendocrine tumors (NETs) and then to investigate the therapeutic value of CS-ESMR. Methods: In this retrospective study, 67 patients who underwent endoscopic treatment of rectal NETs from March 2017 to December 2021 were analyzed. According to the endoscopic resection methods (endoscopic mucosal resection [EMR], CS-ESMR, and endoscopic submucosal dissection [ESD]), the cases were divided into CS-ESMR group (27 cases), ESD group (31 cases), and EMR group (9 cases). The pathological R0 resection rate and the incidence of adverse events (bleeding and perforation) were compared among the three groups. Results: There was a significant difference about the pathological R0 resection between the CS-ESMR group and the EMR group and between the CS-ESMR group and the ESD group (both p < 0.05). Compared with ESD group, the procedure time, intraoperative bleeding, and the cost of CS-ESMR group are significantly decreased (p < 0.001, p < 0.05, p < 0.001, respectively). Conclusion: CS-ESMR may be a safe and effective treatment for rectal NETs with a diameter of less than 10 mm, without muscularis propria invasion and metastasis.

Neuroendocrine tumors (NETs), originated from neuroendocrine cells, can occur in any part of the body where neuroendocrine cells exist. Rectum is one of the most common primary locations of NETs [1, 2], accounting for about 27% of all gastroenteropancreatic NETs [3]. Although rectal NETs are potentially malignant [4], most of them have no specific clinical manifestations and are detected accidentally during screening colonoscopy [5].

It is reported that about 80% of rectal NETs have a diameter ≤10 mm, about 15% are 11–19 mm, and only about 5% have a diameter ≥20 mm [6, 7]. It is recommended by the 2016 guidelines of the European Neuroendocrine Tumor Society that endoscopic resection is feasible for highly differentiated rectal NETs with a diameter <20 mm, without muscularis propria invasion and lymph node metastasis [8, 9]. Endoscopic resection was recommended for rectal NETs with small size because of its prognosis as effective as surgery [8], minimal invasiveness, soon recovery, low cost, and better life quality after treatment. At present, many endoscopic techniques are widely applied for local resection of rectal NETs, including endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) [10, 11]. However, EMR has risk of incomplete resection, while ESD requires special instruments and complex skills.

In this study, we introduce a new endoscopic technology, clip-and-snare assisted endoscopic submucosal resection (CS-ESMR), for treatment of rectal NETs with diameter ≤10 mm and then to investigate the therapeutic value of CS-ESMR, including pathological R0 resection and adverse events, such as bleeding, perforation, and postoperative infection compared with EMR and ESD.

Patients

This retrospective study was performed at the First Affiliated Hospital of Dalian Medical University. A total of 67 patients were diagnosed rectal NETs by endoscopy from March 2017 to December 2021. Tiny rectal NETs or lesions misdiagnosed as sessile polyps were treated by EMR in outpatient department. Patients diagnosed with rectal NET were assigned to Jinpu Branch Hospital and Changchun Road Branch Hospital according to patients’ wishes. Inclusion criteria: patients who had received endoscopic resection for rectal NETs with diameter ≤10 mm and diagnosis of rectal NET had been confirmed by pathology. Exclusion criteria are (1) cases with incomplete data; (2) lesions with identified lymph node or distant metastasis by abdominal CT; (3) lesions with identified invasion of muscularis propria by endoscopic ultrasound; (4) tumor stage was G3; (5) acute anorectal infection, such as anal fissure and perianal abscess; (6) severe coagulation dysfunction; (7) severe cardiac and pulmonary insufficiency; (8) pregnancy; and (9) less than 18 years old.

According to the endoscopic resection methods, the cases were divided into three groups: CS-ESMR group (Jinpu Branch Hospital), ESD group (Changchun Road Branch Hospital), and EMR group (tiny rectal NETs or the lesion like a sessile polyp). The reporting of this study conforms to STROBE guidelines [12]. The study was executed according to the Helsinki Declaration, followed the local legislation, and was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (Ethics Reference No.: PJ-KS-KY-2021-96X, date of approval: June 16, 2021). All the patients or their relatives presented written informed consent before the procedure. Clinicopathological features including gender, age, tumor size, resection methods (EMR, CS-ESMR, ESD), time required for endoscopic resection and consumptive material, the incidence of adverse events (bleeding and perforation), pathological information (including tumor differentiation, depth of tumor invasion, immunohistochemistry, and R0 resection or not) were all recorded.

Procedures

Before the procedure, routine blood tests, coagulation function, liver and kidney function, and electrocardiogram were performed. Endoscopic ultrasound was performed to determine the depth of the lesion, and abdominal CT was performed to exclude lymph node metastasis and distant metastasis. All results were documented.

The CS-ESMR procedure was performed using a transparent cap-covered single-channel upper gastrointestinal endoscope (GIF-H260J, Olympus Optical Co.) with a pre-attached snare (Fig. 1a). After finding the rectal NET (Fig. 1b), a reopenable clip (Hangzhou AGS Bio Tech) was inserted through the working channel of the endoscope to grasp the mucosa adjacent to the lesion (Fig. 1c). When the lesion and surrounding tissues were well elevated by the reopenable clip like a pedicled polyp, the snare was released from the transparent cap, and the mucosa, submucosal lesion, and even some intrinsic muscle layers were completely snared. Then the NET was entirely excised with standard polypectomy technique (Fig. 1d), and the surgical wound was observed for signs of perforation, bleeding, and residual lesion (Fig. 1e). The wound was closed by the lifting reopenable clip and further clips (Fig. 1f) to prevent perforation and bleeding [13] (see online suppl. Video; for all online suppl. material, see https://doi.org/10.1159/000533393). Submucosal injection of solution is not required during the procedure. EMR and ESD were performed as previously described [14, 15].

Fig. 1.

Endoscopic procedure of a rectal NET using CS-ESMR technique. a Place the snare on the transparent cap outside the enteroscope and tighten the steel ring. b Endoscopy showed a submucosal lesion with typical NET features. c The lesion is grasped and lifted by a reopenable clip and separated it from muscularis propria. d The snare was released from the transparent cap, and the lesion was completely snared. e The lesion was completely resected, and a clean surgical wound was displayed. f The wound was perfectly closed with clips.

Fig. 1.

Endoscopic procedure of a rectal NET using CS-ESMR technique. a Place the snare on the transparent cap outside the enteroscope and tighten the steel ring. b Endoscopy showed a submucosal lesion with typical NET features. c The lesion is grasped and lifted by a reopenable clip and separated it from muscularis propria. d The snare was released from the transparent cap, and the lesion was completely snared. e The lesion was completely resected, and a clean surgical wound was displayed. f The wound was perfectly closed with clips.

Close modal

Intraoperative bleeding refers to active bleeding during a procedure requiring electrocoagulation, while post-procedure bleeding is defined as rectal bleeding requiring transfusion and/or endoscopic therapy within 14 days after the resection; endoscopic perforation is defined as a transmural wall defect of the rectum related to the procedure [2]. The procedure time which is referring to the resection process only was recorded.

Pathological evaluation: according to WHO classification standard in 2010, NETs were graded as G1, G2, and G3 according to cell proliferation ability. G1: the number of mitoses is <2/high power field, and the positive index of Ki-67 is ≤2%; G2: the number of mitoses is 2–20/high power field, and the positive index of Ki-67 is 2–20%; G3: the number of mitoses is >20/high power field, and the positive index of Ki-67 is >20% [16, 17]. The depth of invasion, whether combined with other pathological components, surgical margin, vascular or nerve invasion, and so on, were all evaluated.

Pathological complete resection (R0) refers to an en bloc resection of the lesion, with no tumor cells identified at lateral and deep margins, while R1 resection was defined as an en bloc resection of the lesion with margins involved with tumor cells, which implied potential residual tumor on the resection bed [2, 15].

Statistical Analysis

Data analysis was performed using the SPSS 23.0 software (Chicago, IL, USA). All measurement data were expressed by mean ± standard deviation. χ2 test was used for counting data, t test was used for measurement data, and Bonferroni correction was used for comparative analysis. p < 0.05 was considered statistically significant.

According to the exclusion criteria above, a total of 67 patients with rectal NETs were enrolled in this study. All the cases were single lesions and underwent endoscopic resection for the first time. Among them were 32 males (47.8%) and 35 females (52.2%), whose ages ranged from 21 to 76 years, with an average age of 50.4 ± 13.2 years. The distance from the tumor to the anus was 3–14 cm. The tumor diameter is 3–10 mm, with an average diameter of 6.3 ± 2.0 mm.

There were 27 cases in CS-ESMR group, 31 cases in the ESD group, and 9 cases in the EMR group. According to the WHO classification, G1 was found in 64 (95.5%) patients and G2 in 3 (4.5%) patients. The tumors were resected en bloc in all 67 cases. There were 55 cases of pathological R0 resection and 12 cases of R1 resection (7 cases in the ESD group and 5 cases in the EMR group). The patients with R1 resection of rectal NETs had a follow-up period of 20–53 months, and there was no case of local recurrence or distal metastasis. The clinical characteristics and follow-up outcomes of 12 cases with R1 resection are shown in Table 1.

Table 1.

Clinical characteristics and follow-up outcomes of 12 cases with R1 resection

No.Sex/ageTumor locationTumor sizeEndoscopic methodTumor marginLVILR or DMFollow-up period
Male/38 10 cm AV 6 mm ESD LM(+)/VM(−) − − 39 months 
Male/54 7 cm AV 6 mm ESD LM(+)/VM(−) − − 52 months 
Female/61 5 cm AV 5 mm ESD LM(−)/VM(+) − − 53 months 
Male/36 5 cm AV 4 mm ESD LM(−)/VM(+) − − 27 months 
Male/56 3 cm AV 7 mm ESD LM(−)/VM(+) − − 27 months 
Female/47 7 cm AV 5 mm ESD LM(−)/VM(+) − − 37 months 
Male/70 5 cm AV 8 mm ESD LM(−)/VM(+) − − 46 months 
Male/38 5 cm AV 5 mm EMR LM(−)/VM(+) − − 20 months 
Female/72 4 cm AV 4 mm EMR LM(−)/VM(+) − − 21 months 
10 Male/48 5 cm AV 7 mm EMR LM(−)/VM(+) − − 24 months 
11 Female/59 10 cm AV 7 mm EMR LM(−)/VM(+) − − 29 months 
12 Female/65 7 cm AV 6 mm EMR LM(−)/VM(+) − − 50 months 
No.Sex/ageTumor locationTumor sizeEndoscopic methodTumor marginLVILR or DMFollow-up period
Male/38 10 cm AV 6 mm ESD LM(+)/VM(−) − − 39 months 
Male/54 7 cm AV 6 mm ESD LM(+)/VM(−) − − 52 months 
Female/61 5 cm AV 5 mm ESD LM(−)/VM(+) − − 53 months 
Male/36 5 cm AV 4 mm ESD LM(−)/VM(+) − − 27 months 
Male/56 3 cm AV 7 mm ESD LM(−)/VM(+) − − 27 months 
Female/47 7 cm AV 5 mm ESD LM(−)/VM(+) − − 37 months 
Male/70 5 cm AV 8 mm ESD LM(−)/VM(+) − − 46 months 
Male/38 5 cm AV 5 mm EMR LM(−)/VM(+) − − 20 months 
Female/72 4 cm AV 4 mm EMR LM(−)/VM(+) − − 21 months 
10 Male/48 5 cm AV 7 mm EMR LM(−)/VM(+) − − 24 months 
11 Female/59 10 cm AV 7 mm EMR LM(−)/VM(+) − − 29 months 
12 Female/65 7 cm AV 6 mm EMR LM(−)/VM(+) − − 50 months 

AV, anal verge; LM, lateral margin; VM, vertical margin; LVI, lymphovascular invasion; LR, local recurrence; DM, distal metastasis.

There were 12 cases of active bleeding (stopped after electrocoagulation) and 2 cases of perforation (stitched with clips) during the procedures; all these cases were in the ESD groups. There was no post-procedure bleeding and perforation case. There was no significant difference in tumor diameter among the three groups. There was a significant difference about pathological R0 resection between CS-ESMR group and EMR group (p < 0.05) and between the CS-ESMR group and the ESD group (p < 0.05). There was a significant difference about intraoperative bleeding between the CS-ESMR group and the ESD group (p < 0.05), but no significant difference in intraoperative perforation between the two groups (p > 0.05). The procedure time of CS-ESMR group is significantly less than that of ESD group (p < 0.001). Moreover, the cost of CS-ESMR group was significantly less than that of ESD group (p < 0.001) (Table 2).

Table 2.

Basic data, pathological grade, resection, and adverse events of patients in three groups

CS-ESMR group (n = 27)ESD group (n = 31)EMR group (n = 9)p value
Gender 
 Male, n 10 19  
Age 
 Range, years 26–73 21–70 33–76  
 Average age, years 49.3±13.7 49.4±12.4 56.2±14.5 ap > 0.999, bp = 0.543 
 ≥60 years old, n  
Tumor diameter, mm 
 Diameter range 3–10 3–10 4–10  
 Average diameter 6.4±1.9 6.1±2.0 6.0±1.9 ap > 0.999, bp > 0.999 
Pathological grade, n 
 G1 26 29 ap > 0.05, bp > 0.05 
 G2  
R0 resection, n 27 24 ap < 0.05, bp < 0.05 
R1 resection, n  
Procedure time, min 2.5±1.8 14.3±7.0 3.8±1.0 ap < 0.001, bp > 0.999 
Adverse events, n 
 Intraoperative bleeding 12 ap < 0.05 
 Intraoperative perforation ap > 0.05 
 Postoperative bleeding  
 Postoperative perforation  
Cost, ¥ (Tables 3 and 42,400±208 8,595±1,646 2,660±240 ap < 0.001 bp > 0.999 
CS-ESMR group (n = 27)ESD group (n = 31)EMR group (n = 9)p value
Gender 
 Male, n 10 19  
Age 
 Range, years 26–73 21–70 33–76  
 Average age, years 49.3±13.7 49.4±12.4 56.2±14.5 ap > 0.999, bp = 0.543 
 ≥60 years old, n  
Tumor diameter, mm 
 Diameter range 3–10 3–10 4–10  
 Average diameter 6.4±1.9 6.1±2.0 6.0±1.9 ap > 0.999, bp > 0.999 
Pathological grade, n 
 G1 26 29 ap > 0.05, bp > 0.05 
 G2  
R0 resection, n 27 24 ap < 0.05, bp < 0.05 
R1 resection, n  
Procedure time, min 2.5±1.8 14.3±7.0 3.8±1.0 ap < 0.001, bp > 0.999 
Adverse events, n 
 Intraoperative bleeding 12 ap < 0.05 
 Intraoperative perforation ap > 0.05 
 Postoperative bleeding  
 Postoperative perforation  
Cost, ¥ (Tables 3 and 42,400±208 8,595±1,646 2,660±240 ap < 0.001 bp > 0.999 

ap: CS-ESMR group vs. ESD group.

bp: CS-ESMR group vs. EMR group.

Rectal NETs are uncommon in clinic and account for only about 1.8% of all rectal tumors [15, 18]. However, with the development of endoscopy, the incidence of rectal NETs has increased worldwide in recent years [19], from 0.1/100 thousand in 1973 to 1.15/100 thousand, increased by 10 times in 40 years [20]. Endoscopically, rectal NETs are generally located in the middle and lower part of the rectum as a slight protrusion with smooth surface and yellow color, usually small in size (<10 mm), and seldom present as multiple, hyperemic surfaces, ulcers, or pedicles [2].

Table 3.

The device used for each treatment method (CS-ESMR, ESD, EMR) and the total cost of the three groups

Dual knifeCoagrasperInjectorClipsSnareOperation cost, ¥Total cost, ¥
ESD 0–1 0–3 2,860 7,400∼10,370 
EMR 0–3 1,540 2,420∼2,960 
CS-ESMR 1–4 1,540 2,080∼2,620 
Dual knifeCoagrasperInjectorClipsSnareOperation cost, ¥Total cost, ¥
ESD 0–1 0–3 2,860 7,400∼10,370 
EMR 0–3 1,540 2,420∼2,960 
CS-ESMR 1–4 1,540 2,080∼2,620 
Table 4.

The cost of each device used for each treatment method (CS-ESMR, ESD, EMR)

MaterialsModel, No.Cost, ¥
Dual knife KD-650Q Olympus 4,020 
Coagrasper FD-411QR Olympus 2,430 
Injector NM-400U-0425 Olympus 520 
Clip AG-5102-1950-135 Hangzhou AGS Bio Tech 180 
Snare AG-5071-241523 Hangzhou AGS Bio Tech 360 
MaterialsModel, No.Cost, ¥
Dual knife KD-650Q Olympus 4,020 
Coagrasper FD-411QR Olympus 2,430 
Injector NM-400U-0425 Olympus 520 
Clip AG-5102-1950-135 Hangzhou AGS Bio Tech 180 
Snare AG-5071-241523 Hangzhou AGS Bio Tech 360 

Since about 80% of rectal NETs are less than 10 mm in diameter [21], the risk of metastasis is very low for small rectal NETs [22], and endoscopic local resection is widely recommended [10]. Polypectomy and EMR are simple and safe but have risk of incomplete resection. It is reported that pathological R0 resection of EMR for rectal NETs ranges from 30% to 70% [23‒25]. Nakamura et al. [24] reported in 2016 that the pathological R0 resection of EMR is only 27.3%, and patients with incomplete resection need to be treated again because of tumor residue. In our study, the pathological R0 resection was 44.4% (4/9) in EMR group. The results are consistent with the previous reports and indicate that conventional EMR is not a suitable method for local resection of rectal NETs because of the presence of submucosal layer involvement [14].

In recent years, more and more studies about ESD for rectal NETs have been reported. Compared with EMR, ESD has advantages of higher pathological R0 resection and lower recurrence [26, 27]. In our study, the pathological R0 resection by ESD was lower than in previous studies [27]. The reason is mainly attributable to lack of ESD experience. Our study showed that the pathological R0 resection in ESD group was significantly higher than that in EMR group. However, ESD require advanced skills, it takes more time to learn, procedure time is long, and there is a risk of complications [28] with longer hospital stay and more cost. Therefore, a simple and safe technique with high pathological R0 resection is needed. CS-ESMR meets the above requirements. Since small size rectal NETs are limited to the submucosal layer without lymphovascular invasion [29], CS-ESMR demonstrated a high R0 resection rate and excellent long-term prognosis. During the procedure of CS-ESMR, the lesion and surrounding tissues were grasped and lifted by a reopenable clip, then the mucosa and submucosal lesion were completely resected by a snare, and even partial intrinsic muscle layer was resected in some cases. In our study, CS-ESMR group had higher pathological R0 resection, with lower intraoperative bleeding and perforation, which indicates CS-ESMR is a safe and effective method. CS-ESMR causes small trauma and recovery rapidly, which means shorter hospital stay. Another advantage of CS-ESMR is taking less time. It is reported that the median operation time of ESD is 25 min (10–49 min) [30]. In our study, the procedure time of CS-ESMR is no more than 5 min, significantly less than that of ESD group. Moreover, compared with ESD, CS-ESMR requires less consumptive material, so the cost is significantly reduced.

EMR with a ligating device (EMR-L) has been reported effective for resection of rectal NETs. Previous studies have shown that the rate of R0 resection is similar to that of ESD [31, 32]. Compared with EMR-L, the rectal NET is completely snared more easily using CS-ESMR method, even for the lesions below the endoscopic screen, since the lesion is grasped and lifted by a reopenable clip and separated from muscularis propria. In addition, economic factor is another advantage for CS-ESMR. Furthermore, the procedure is simple and saves time.

Lee et al. [33] reported that EMR using a dual-channel endoscope is a safe and effective technique for resection of small rectal NETs within the submucosa. By lifting the lesion with grasping forceps to separate it from the muscularis propria and strangling the base with a snare through another channel, this method enables satisfied R0 resection rates similar to ESD. However, dual-channel endoscope is not available in most hospitals. Our technique is enlightened by dual-channel endoscopic therapy, which accomplishes the whole procedure, including lifting the lesion by a reopenable clip, strangling the base, resecting the rectal NETs with a snare, and closing the wound with clips through a single-channel endoscope.

It is reported that underwater EMR is a simple and inexpensive new technique for treatment of rectal NETs, with high R0 resection and low adverse events. However, for flat (not so much protruded) lesions, it may be difficult to achieve R0 resection [34, 35].

Endoscopic full-thickness resection, an ultraminimally invasive endoscopic surgery, is mainly used in the treatment of a tumor of the gastrointestinal tract wall [36[36, 38‒40]. By full-wall resection, endoscopic full-thickness resection has advantages of a high R0 resection rate and a relatively low risk of recurrence for submucosal tumors less than 20 mm [37, 38]. However, since it is an active perforation endoscopic technique, wound closure was required by suture instruments (for example, the over-the-scope clip), which increased cost and time of the procedure.

In our study, 12 cases with R1 resection of rectal NETs had a follow-up period of 20–53 months. Theoretically, positive lateral or vertical margin involvement is a potential risk factor for local recurrence. But there was no case of local recurrence or distal metastasis in this study. It may be attributed to the destruction of the neighboring tumor cells by cauterization during EMR and ESD. Park et al. reported that residual tumor cells were found in only 10% of patients considered for R1 resection [11]. So, for R1 resection patients with no signs of poor prognosis, over-treatment should be avoided, especially for elderly patients [2]. Lymphovascular invasion has been regarded as the most important factor for the spread of cancer cells and lymph node metastasis [39]. But Kang et al. [40] point out that endoscopically resected small rectal NETs, even with lymphovascular invasion, are not absolutely necessary for immediate completion of radical surgery. Of course, longer-term follow-up is still necessary.

However, this was a nonrandomized retrospective study conducted in a single center, and all published data on the subject are predominantly retrospective. Small sample was another limitation of the study. In addition, technical differences may present between the endoscopists who performed the procedures. Furthermore, CS-ESMR works well when the lesion is located in the rectum but is likely to have limitations at the proximal colon due to the outward positioning of the snare. A multicenter trial with more cases and long-time follow-up is required to confirm the value of CS-ESMR in treatment of rectal neuroendocrine tumors.

CS-ESMR may be a safe and effective treatment for rectal NETs with a small size (no more than 10 mm), no invasion of the muscularis propria, and no metastasis. It has many advantages: the procedure is easy, simple, less time-consuming with high pathological R0 resection, low risk of adverse events such as bleeding and perforation, low cost, and rapid recovery.

We would like to acknowledge the contribution of the colleagues of the department of endoscopy and pathology at the First Affiliated Hospital of Dalian Medical University.

The study was conducted in compliance with the Helsinki Declaration and in accordance with local legislation, was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (Ethics Reference No.: PJ-KS-KY-2021-96X). Written informed consent was obtained from all of the patients or their relatives before the procedure.

The authors have no conflicts of interest to declare.

No funding was obtained for this study.

Shi-Bin Guo and Jian Gong designed the study and have equal contribution. Xin-Tong Jiang and Yang Hu collected and analyzed the data, wrote the manuscript, and have equal contribution. Shi-Bin Guo edited the manuscript. All authors have read and approved the manuscript.

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

1.
Gastrointestinal Pathology Study Group of Korean Society of Pathologists
Cho
MY
,
Kim
JM
,
Sohn
JH
,
Kim
MJ
,
Kim
KM
.
Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in korea 2000-2009: multicenter study
.
Cancer Res Treat
.
2012
;
44
(
3
):
157
65
.
2.
Fine
C
,
Roquin
G
,
Terrebonne
E
,
Lecomte
T
,
Coriat
R
,
Do Cao
C
.
Endoscopic management of 345 small rectal neuroendocrine tumours: a national study from the French group of endocrine tumours (GTE)
.
United Eur Gastroenterol J
.
2019
;
7
(
8
):
1102
12
.
3.
Anthony
LB
,
Strosberg
JR
,
Klimstra
DS
,
Maples
WJ
,
O'Dorisio
TM
,
Warner
RRP
.
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum
.
Pancreas
.
2010
;
39
(
6
):
767
74
.
4.
Soga
J
.
Carcinoids of the rectum: an evaluation of 1271 reported cases
.
Surg Today
.
1997
;
27
(
2
):
112
9
.
5.
Ramage
JK
,
De Herder
WW
,
Delle Fave
G
,
Ferolla
P
,
Ferone
D
,
Ito
T
.
ENETS consensus guidelines update for colorectal neuroendocrine neoplasms
.
Neuroendocrinology
.
2016
;
103
(
2
):
139
43
.
6.
de Mestier
L
,
Lorenzo
D
,
Fine
C
,
Cros
J
,
Hentic
O
,
Walter
T
.
Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors
.
Best Pract Res Clin Endocrinol Metab
.
2019
;
33
(
5
):
101293
.
7.
Basuroy
R
,
Haji
A
,
Ramage
JK
,
Quaglia
A
,
Srirajaskanthan
R
.
Review article: the investigation and management of rectal neuroendocrine tumours
.
Aliment Pharmacol Ther
.
2016
;
44
(
4
):
332
45
.
8.
Caplin
M
,
Sundin
A
,
Nillson
O
,
Baum
RP
,
Klose
KJ
,
Kelestimur
F
.
ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms
.
Neuroendocrinology
.
2012
;
95
(
2
):
88
97
.
9.
Kaltsas
G
,
Caplin
M
,
Davies
P
,
Ferone
D
,
Garcia-Carbonero
R
,
Grozinsky-Glasberg
S
.
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pre- and perioperative therapy in patients with neuroendocrine tumors
.
Neuroendocrinology
.
2017
;
105
(
3
):
245
54
.
10.
Kim
HH
,
Park
SJ
,
Lee
SH
,
Park
HU
,
Song
CS
,
Park
MI
.
Efficacy of endoscopic submucosal resection with a ligation device for removing small rectal carcinoid tumor compared with endoscopic mucosal resection: analysis of 100 cases
.
Dig Endosc
.
2012
;
24
(
3
):
159
63
.
11.
Park
CH
,
Cheon
JH
,
Kim
JO
,
Shin
JE
,
Jang
BI
,
Shin
SJ
.
Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread
.
Endoscopy
.
2011
;
43
(
9
):
790
5
.
12.
von Elm
E
,
Altman
DG
,
Egger
M
,
Pocock
SJ
,
Gøtzsche
PC
,
Vandenbroucke
JP
.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
.
Ann Intern Med
.
2007
;
147
(
8
):
573
7
.
13.
Liu
WH
,
Liu
S
,
Gong
Y
,
Kobara
H
,
Guo
SB
,
Gong
J
.
Cut the weeds and dig up the roots: clip-and-snare assisted endoscopic mucosal resection of a rectal neuroendocrine tumor
.
Endoscopy
.
2021
53
1
E13
4
.
14.
Kim
J
,
Kim
JH
,
Lee
JY
,
Chun
J
,
Im
JP
,
Kim
JS
.
Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor
.
BMC Gastroenterol
.
2018
;
18
(
1
):
77
.
15.
Lim
HK
,
Lee
SJ
,
Baek
DH
,
Park
DY
,
Lee
BE
,
Park
EY
.
Resectability of rectal neuroendocrine tumors using endoscopic mucosal resection with a ligation band device and endoscopic submucosal dissection
.
Gastroenterol Res Pract
.
2019
;
2019
:
8425157
.
16.
Niederle
MB
,
Hackl
M
,
Kaserer
K
,
Niederle
B
.
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters
.
Endocr Relat Cancer
.
2010
;
17
(
4
):
909
18
.
17.
Păun
I
,
Becheanu
G
,
Costin
AI
,
Constantin
VD
,
Mihai
GM
,
Radu
L
.
Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system: a review
.
Rom J Morphol Embryol
.
2018
;
59
(
3
):
673
8
.
18.
Pyo
JH
,
Hong
SN
,
Min
BH
,
Lee
JH
,
Chang
DK
,
Rhee
PL
.
Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center
.
J Gastroenterol
.
2016
;
51
(
12
):
1112
21
.
19.
Hyun
JH
,
Lee
SD
,
Youk
EG
,
Lee
JB
,
Lee
EJ
,
Chang
HJ
.
Clinical impact of atypical endoscopic features in rectal neuroendocrine tumors
.
World J Gastroenterol
.
2015
;
21
(
47
):
13302
8
.
20.
Dasari
A
,
Shen
C
,
Halperin
D
,
Zhao
B
,
Zhou
S
,
Xu
Y
.
Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States
.
JAMA Oncol
.
2017
;
3
(
10
):
1335
42
.
21.
Modlin
IM
,
Oberg
K
,
Chung
DC
,
Jensen
RT
,
de Herder
WW
,
Thakker
RV
.
Gastroenteropancreatic neuroendocrine tumours
.
Lancet Oncol
.
2008
;
9
(
1
):
61
72
.
22.
Al Natour
RH
,
Saund
MS
,
Sanchez
VM
,
Whang
EE
,
Sharma
AM
,
Huang
Q
.
Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection
.
J Gastrointest Surg
.
2012
;
16
(
3
):
595
602
.
23.
Yang
DH
,
Park
Y
,
Park
SH
,
Kim
KJ
,
Ye
BD
,
Byeon
JS
.
Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos)
.
Gastrointest Endosc
.
2016
;
83
(
5
):
1015
22
; quiz 1023-.e6.
24.
Nakamura
K
,
Osada
M
,
Goto
A
,
Iwasa
T
,
Takahashi
S
,
Takizawa
N
.
Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification
.
Scand J Gastroenterol
.
2016
;
51
(
4
):
448
55
.
25.
Jeon
JH
,
Cheung
DY
,
Lee
SJ
,
Kim
HJ
,
Kim
HK
,
Cho
HJ
.
Endoscopic resection yields reliable outcomes for small rectal neuroendocrine tumors
.
Dig Endosc
.
2014
;
26
(
4
):
556
63
.
26.
Zhang
HP
,
Wu
W
,
Yang
S
,
Lin
J
.
Endoscopic treatments for rectal neuroendocrine tumors smaller than 16 mm: a meta-analysis
.
Scand J Gastroenterol
.
2016
;
51
(
11
):
1345
53
.
27.
He
L
,
Deng
T
,
Luo
H
.
Efficacy and safety of endoscopic resection therapies for rectal carcinoid tumors: a meta-analysis
.
Yonsei Med J
.
2015
;
56
(
1
):
72
81
.
28.
Zhou
X
,
Xie
H
,
Xie
L
,
Li
J
,
Cao
W
,
Fu
W
.
Endoscopic resection therapies for rectal neuroendocrine tumors: a systematic review and meta-analysis
.
J Gastroenterol Hepatol
.
2014
;
29
(
2
):
259
68
.
29.
Sekiguchi
M
,
Sekine
S
,
Sakamoto
T
,
Otake
Y
,
Nakajima
T
,
Matsuda
T
.
Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion
.
J Gastroenterol
.
2015
;
50
(
12
):
1184
9
.
30.
Park
HJ
,
Park
HW
,
Lee
SJ
,
Arevalo
JC
,
Park
YS
,
Lee
SP
.
Endoscopic submucosal dissection for treatment of rectal carcinoid tumors
.
J Gastroenterol Hepatol
.
2010
;
72
(
1
):
143
9
.
31.
Mashimo
Y
,
Matsuda
T
,
Uraoka
T
,
Saito
Y
,
Sano
Y
,
Fu
K
.
Endoscopic submucosal resection with a ligation device is an effective and safe treatment for carcinoid tumors in the lower rectum
.
J Gastroenterol Hepatol
.
2008
;
23
(
2
):
218
21
.
32.
Lee
J
,
Park
YE
,
Choi
JH
,
Heo
NY
,
Park
J
,
Park
SH
.
Comparison between cap-assisted and ligation-assisted endoscopic mucosal resection for rectal neuroendocrine tumors
.
Ann Gastroenterol
.
2020
;
33
(
4
):
385
90
.
33.
Lee
WH
,
Kim
SW
,
Lim
CH
,
Kim
JS
,
Cho
YK
,
Lee
IS
.
Efficacy of endoscopic mucosal resection using a dual-channel endoscope compared with endoscopic submucosal dissection in the treatment of rectal neuroendocrine tumors
.
Surg Endosc
.
2013
;
27
(
11
):
4313
8
.
34.
Park
SS
,
Han
KS
,
Kim
B
,
Chang Kim
B
,
Hong
CW
,
Sohn
DK
.
Comparison of underwater endoscopic mucosal resection and endoscopic submucosal dissection of rectal neuroendocrine tumors (with videos)
.
Gastrointest Endosc
.
2020
;
91
(
5
):
1164
71.e2
.
35.
Yamashina
T
,
Tumura
T
,
Maruo
T
,
Matsumae
T
,
Yoshida
H
,
Tanke
G
.
Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter
.
Endosc Int Open
.
2018
6
1
E111
14
.
36.
Wang
K
,
Gao
P
,
Cai
M
,
Song
B
,
Zhou
P
.
Endoscopic full-thickness resection, indication, methods and perspectives
.
Dig Endosc
.
2023
;
35
(
2
):
195
205
.
37.
McKechnie
T
,
Govind
S
,
Lee
J
,
Lee
Y
,
Hong
D
,
Eskicioglu
C
.
Endoscopic full-thickness resection for colorectal lesions: a systematic review and meta-analysis
.
J Surg Res
.
2022
;
280
:
440
9
.
38.
Dolan
RD
,
Bazarbashi
AN
,
McCarty
TR
,
Thompson
CC
,
Aihara
H
.
Endoscopic full-thickness resection of colorectal lesions: a systematic review and meta-analysis
.
Gastrointest Endosc
.
2022
;
95
(
2
):
216
24.e18
.
39.
Ishii
M
,
Ota
M
,
Saito
S
,
Kinugasa
Y
,
Akamoto
S
,
Ito
I
.
Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer
.
Int J Colorectal Dis
.
2009
;
24
(
9
):
1069
74
.
40.
Kang
HS
,
Kwon
MJ
,
Kim
TH
,
Han
J
,
Ju
YS
.
Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: a systematic review and meta-analysis
.
Pathol Res Pract
.
2019
;
215
(
11
):
152642
.